Find Reports

Select Report Type

Reimbursement Review

Displaying 1001 - 1025 of 1258

Please scroll or swipe to the right to view the full content.

Brand Name	Generic Name	Files	Therapeutic Area	Recommendation Type	Status	Submission Date	Recommendation Date Sort ascending	Project Number
Gynazole.1	Butoconazole nitrate	cdr_tracking_Gynazole.1.pdf	Vaginal infection	Do not list	Complete	Jun 30, 2004	Jan 26, 2005	SR0017-000
Avodart	Dutasteride	cdr_tracking_Avodart.pdf cdr_complete_Avodart_2005Jan24.pdf	Prostatic hyperplasia, benign	List in a similar manner to other drugs in class	Complete	Aug 24, 2004	Jan 20, 2005	SR0019-000
Forteo	Teriparatide (rDNA origin) injection	cdr_tracking_Forteo.pdf cdr_complete_Forteo_2004Dec22.pdf	Osteoporosis	Do not list	Complete	Jun 8, 2004	Dec 22, 2004	SR0015-000
Teveten Plus	Eprosartan mesylate/ hydrochlorothiazide		Hypertension, Essential	List in a similar manner to other drugs in class	Complete	Jul 8, 2004	Dec 15, 2004	SR0016-000
Replagal	Agalsidase alfa	cdr_tracking_replagal.pdf cdr_complete_Replagal_2004Nov24.pdf	Fabry Disease	Do not list	Complete	Feb 19, 2004	Nov 24, 2004	SR0006-000
Fabrazyme	Agalsidase beta	cdr_tracking_Fabrazyme.pdf cdr_complete_Fabrazyme_2004Nov24.pdf	Fabry Disease	Do not list	Complete	Feb 24, 2004	Nov 24, 2004	SR0007-000
Adderall XR	Mixed amphetamine salts	cdr_tracking_Adderall.pdf cdr_complete_AdderallXR_2004Nov24.pdf	Attention deficit hyperactivity disorder	Do not list	Complete	Apr 13, 2004	Nov 24, 2004	SR0010-000
Zavesca	Miglustat	cdr_tracking_Zavesca.pdf cdr_complete_Zavesca_2004Nov24.pdf	Gaucher disease	Do not list	Complete	May 13, 2004	Nov 24, 2004	SR0012-000
Remodulin	Treprostinil sodium	cdr_tracking_Remodulin.pdf cdr_complete_Remodulin (treprostinil)_Nov17_04.pdf	Pulmonary arterial hypertension (NYHA Class III and IV patients)	Do not list	Complete	Jul 14, 2004	Nov 17, 2004	SR0011-000
Neulasta	Pegfilgrastim	cdr_tracking_neulasta.pdf cdr_complete_neulasta_10-27-04.pdf	Neutropenia	List with clinical criteria and/or conditions	Complete	Mar 29, 2004	Oct 27, 2004	SR0009-000
Pegasys RBV	Peginterferon alfa-2a and Ribavirin	cdr_complete_Pegasys_10_14_04.pdf	Hepatitis C, chronic	List in a similar manner to other drugs in class	Complete	May 14, 2004	Oct 14, 2004	SR0013-000
Viread	Tenofovir disoproxil fumarate	cdr_tracking_Viread.pdf cdr_complete_viread_08-25-04.pdf	HIV infection	Do not list	Complete	Feb 23, 2004	Aug 25, 2004	SR0008-000
Iressa	Gefitinib	cdr_tracking_Iressa.pdf cdr_complete_iressa_06-23-04.pdf	Cancer, Lung , non-small cell	Do not list	Complete	Dec 22, 2003	Jun 23, 2004	SR0003-000
Evra	Norgelestromin/ethinyl estradiol	cdr_tracking_EVRA.pdf cdr_complete_Evra_06-23-04.pdf	Contraceptive, patch	Do not list	Complete	Dec 19, 2003	Jun 23, 2004	SR0004-000
Combigan Ophthalmic Solution	Brimonidine tartrate/timolol maleate	cdr_tracking_Combigan.pdf cdr_complete_Combigan_05-27-04.pdf	Glaucoma	List with clinical criteria and/or conditions	Complete	Dec 15, 2003	May 27, 2004	SR0001-000
Reyataz	Atazanavir	cdr_tracking_Reyataz.pdf cdr_complete_Reyataz_05-27-04.pdf	HIV infection	List in a similar manner to other drugs in class	Complete	Dec 16, 2003	May 27, 2004	SR0002-000
Axert	Almotriptan	cdr_tracking_Axert.pdf cdr_complete_Axert_05-27-04.pdf	Migraine	List in a similar manner to other drugs in class	Complete	Dec 24, 2003	May 27, 2004	SR0005-000
Admelog	Insulin lispro				Cancelled			SE0543-000
Inlyta (RFA)	Axitinib	pcodr_rfa_axitinib_inlyta_mrcc_rfa_rec.pdf pcodr_rfa_axitinib_inlyta_mrcc_rfa_cgr.pdf pcodr_rfa_axitinib_inlyta_mrcc_fdk_pfizer.pdf pcodr_rfa_axitinib_inlyta_mrcc_fdk_kcc.pdf	Metastatic Renal Cell Carcinoma	N/A	Complete	Apr 18, 2017		PA0001-000
Mvasi	Bevacizumab	pcodr_provfund_10158_bevacizumab_mvasi_mcrc_nsclc.pdf 10158MVASI_CADTHBiosimilarSummaryDossier_FINAL_14Jan2019.pdf	mCRC NSCLC Biosimilar	N/A	Complete	Oct 3, 2018		PC0158-000
Xeljanz	tofacitinib				Cancelled			SR0575-000
Beleodaq	Belinostat				Withdrawn	Jun 29, 2018		PC0139-000
Blincyto	Blinatumomab				Withdrawn	Jun 29, 2018		PC0143-000
TBC	filgrastim		Prevention or treatment of neutropenia in various indications		Cancelled	Nov 1, 2018		SE0585-000
Fulphila	pegfilgrastim	se0588-fulphila-biosimilar-dossier.pdf	Febrile neutropenia in non-myeloid malignancies	N/A	Complete	Nov 14, 2018		SE0588-000

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 589 of 589

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 111 of 111

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 40 of 40

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1001 - 1025 of 2093

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
Evidence Update on Direct Oral Anticoagulants for Atrial Fibrillation	Direct Oral Anticoagulants for Atrial Fibrillation	May 27, 2021	Health Technology Review	Technology Review	Completed	HC0018-000
Single-Entry Models in Surgical Services	Single-Entry Models in Surgical Services (Policy Insight)	May 26, 2021	Health Technology Review	Policy Insight	Completed	CY0009-000
onasemnogene abeparvovec	Recommendation and Reasons Clinical Report Pharmacoeconomic Report Patient Group Input Submission Implementation Advice	May 26, 2021	Reimbursement Review		Complete	SG0649-000
Visual Examination Frequency for People Taking Ethambutol for Tuberculosis	Visual Examination Frequency for People Taking Ethambutol for Tuberculosis	May 25, 2021	Health Technology Review	Summary with Critical Appraisal	Completed	RC1343-000
Tuberculosis Screening for People with Chronic Conditions	Tuberculosis Screening for People with Chronic Conditions	May 13, 2021	Health Technology Review	Summary with Critical Appraisal	Completed	RC1345-000
Overview of Formulary Management Practices of Publicly Funded Provincial and Territorial Drug Plans	Overview of Formulary Management Practices of Publicly Funded Provincial and Te…	May 12, 2021	Health Technology Review	Environmental Scan	Completed	ES0354-000
Analysis of FPT Formulary Harmonization: Specialty Care Medications	Analysis of FPT Formulary Harmonization: Specialty Care Medications	May 12, 2021	Health Technology Review	Technology Review	Completed	HD0005-000
Electronic Aids to Daily Living	ES0346 Funding and Access to EADLs Final.pdf	May 6, 2021	Health Technology Review	Environmental Scan	Completed	ES0346-000
Abiraterone (Zytiga) for Prostate Cancer Resubmission - Details		May 6, 2021	Reimbursement Review		Withdrawn	PC0201-000
Polatuzumab Vedotin (Polivy) for DLBCL - Details	10227PolatuzumabDLBCL_fnRec_EC21Apr2021_final.pdf 10227PolatuzumabDLBCL_fnEGR_REDACT-ABBREV_EC21Apr2021_final.pdf 10227PolatuzumabDLBCL_fnCGR_NOREDACT_EC21Apr2021_final.pdf 10227PolatuzumabDLBCL_inRec_pERC Chair Approved_Post01Apr2021_final.pdf 10227PolatuzumabDLBCL_PAG Feedback_EC21Apr2021_final.pdf 10227PolatuzumabDLBCL_SponsorFeedback_EC21Apr2021_final.pdf 10227PolatuzumabDLBCL_PatientFeedback_LC_Final_Redacted.pdf 10227PolatuzumabDLBCL_ClinicianFeedback_CCO_EC21Apr2021_final.pdf 10227PolatuzumabDLBCL_Patient COI_LC_EC21Apr2021_final.pdf 10227PolatuzumabDLBCL_Combined Clinician COIs EC21Apr2021_final_Redacted.pdf	May 6, 2021	Reimbursement Review		Complete	PC0227-000
Brigatinib (Alunbrig) for Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer - Details	10230BrigatinibALK+NSCLC_fnRec_EC21Apr2021_final.pdf 10230BrigatinibALK+NSCLC_fnEGR_REDACT-ABBREV_EC21Apr2021_final.pdf 10230BrigatinibALK+NSCLC_fnCGR_NOREDACT_EC21Apr2021_final.pdf 10230BrigatinibALK+NSCLC_inRec_approvedbyChair_Post01Apr2021_final.pdf 10230BrigatinibALK+NSCLC_PAGFeedback_EC21Apr2021_final.pdf 10230BrigatinibALK+NSCLC_SponsorFeedback_EC21Apr2021_final.pdf 10230BrigatinibALK+NSCLC_PatientFeedback_LCC_EC21Apr2021_final.pdf 10230BrigatinibALK+NSCLC_Combined ClinicianFeedback_EC21Apr2021.pdf 10230BrigatinibALK+NSCLC_Patient COI_EC21Apr2021_final.pdf 10230BrigatinibALK+NSCLC_Combined_COIs EC21Apr2021_final.pdf	May 6, 2021	Reimbursement Review		Complete	PC0230-000
Framework for Drugs for Rare Diseases	es0355-drugs-for-rare-diseases-pw.pdf	May 6, 2021	Horizon Scan	Environmental Scan	Completed	ES0355-000
Treat and Release for Patients Requiring Emergency Medical Services	RC1358 Treat and release - Final.pdf	May 5, 2021	Health Technology Review	Summary with Critical Appraisal		RC1358-000
Interferon Gamma Release Assay for Identifying Latent Tuberculosis Infection in People With Bacillus Calmette-Guérin Vaccination	RC1346 draft Final.pdf	May 5, 2021	Health Technology Review	Summary with Critical Appraisal	Completed	RC1346-000
esketamine hydrochloride	SR0621 Spravato - CDEC Final Recommendation December 18, 2020_for posting.pdf sr0621-spravato-clinical-review-report.pdf sr0621-spravato-pharmacoeconomic-review-report.pdf SR0621_Esketamine_PI Submission.pdf	Apr 30, 2021	Reimbursement Review		Complete	SR0621-000
vedolizumab	SR0647 Entyvio - CDEC Final Recommendation January 22, 2021_for posting.pdf sr0647-entyvio-clinical-economic-review-report.pdf SR0647_Entyvio_PI Submission.pdf	Apr 30, 2021	Reimbursement Review		Complete	SR0647-000
Sonidegib (Odomzo) for Basal Cell Carcinoma - Details	10215SonidegibBCC_fnRec_Post29Apr2021_final.pdf 10215SonidegibBCC_fnEGR_NOREDACT-ABBREV_Post29Apr2021_final.pdf 10215SonidegibBCC_fnCGR_NOREDACT_Post29Apr2021_final.pdf 10215SonidegibBCC_inRec_Post04Mar2021_final.pdf 10215SonidegibBCC_PAGFeedbackSummary_Post29Apr2021_final.pdf 10215SonidegibBCC_SponsorFeedback_Post29Apr2021_final_Redacted.pdf 10215SonidegibBCC_PatientFeedback_Combined_Post29Apr2021_final_Redacted.pdf 10215SonidegibBCC_ClinicianFeedback_CCO_Post29Apr2021_final_Redacted.pdf 10215SonidegibBCC_PatientCOI_Combined_Post29Apr2021_final_Redacted.pdf 10215SonidegibBCC_ClinicianInput_Combined_COIs Post29Apr2021_final_Redacted.pdf	Apr 29, 2021	Reimbursement Review		Complete	PC0215-000
Niraparib (Zejula) for first line Ovarian Cancer - Details	10224NiraparibOC_fnRec_pERC Chair Approved_Post29Apr2021_final.pdf 10224NiraparibOC_fnEGR_REDACT-ABBREV_Post29Apr2021_final.pdf 10224NiraparibOC_fnCGR_NOREDACT_Post29Apr2021_final.pdf 10224NiraparibOC_inRec_pERC Chair Approved_Post04Mar2021_final.pdf 10224NiraparibOC_PAGFeedbackSummary_Post29Apr2021_final_Redacted.pdf 10224NiraparibOC_SponsorFeedback_Post29Apr2021_final.pdf 10224NiraparibOC_PatientFeedback_OCC_Post29Apr2021_final.pdf 10224NiraparibOC_ClinicianFeedback_CCO_Post29Apr2021_final.pdf 10224NiraparibOC_Patient COI_OCC_Post29Apr2021_final.pdf 10224NiraparibOC_Combined Clinician COIs_Post29Apr2021_final.pdf	Apr 29, 2021	Reimbursement Review		Complete	PC0224-000
CADTH Pharmaceutical Reviews Update — Issue 23		Apr 29, 2021	Reimbursement Review	Pharmaceutical Review Update
apomorphine hydrochloride	SR0650 Kynmobi - CDEC Final Recommendation February 26, 2021_For posting.pdf sr0650-kynmobi-clinical-review-report.pdf sr0650-kynmobi-pharmacoeconomic-review-report.pdf Kynmobi - Patient Group Input_For Posting.pdf	Apr 26, 2021	Reimbursement Review		Complete	SR0650-000
Bupropion for Major Depressive Disorder or Persistent Depressive Disorder (Dysthymia)	Bupropion for Major Depressive Disorder or Persistent Depressive Disorder (Dyst…	Apr 26, 2021	Health Technology Review	Summary with Critical Appraisal	Completed	RC1352-000
Onabotulinum Toxin A (Botox) for Spasticity in Patients With Acquired Brain Injury	Onabotulinum Toxin A (Botox) for Spasticity in Patients With Acquired Brain Inj…	Apr 26, 2021	Health Technology Review	Summary with Critical Appraisal		RC1353-000
Unresectable Hepatocellular Carcinoma	Final Report	Apr 21, 2021	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0003-000
nintedanib	SR0654 Ofev - Final CDEC Recommendation February 26, 2021_For Posting.pdf sr0654-ofev-clinical-review-report.pdf sr0654-ofev-pharmacoeconomic-review-report.pdf SR0654 Ofev - Consolidated Patient Input for Posting.pdf	Apr 21, 2021	Reimbursement Review		Complete	SR0654-000
Non-Pharmacological Interventions for the Management of Concussion	de0100-concussion-scoping-summary.pdf	Apr 21, 2021	Health Technology Review	Scoping	Completed	DE0100-000